SCHEMBL5365592

SCHEMBL5365592

Cc1cc(-c2ccc(C#N)cc2)c(C)n1Cc1ccn[nH]1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B2 P19099 4/20 0.41
MLNR O43193 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
AR P10275 7/20 0.38
KCNH2 Q12809 1/20 0.37
LMNA P02545 2/20 0.37
MAPT P10636 2/20 0.37
KDM4E B2RXH2 1/20 0.37
FASN P49327 1/20 0.36
CCNC P24863 1/20 0.36
CDK8 P49336 1/20 0.36
CYP19A1 P11511 2/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
KLKB1 P03952 1/20 0.34
KLK1 P06870 1/20 0.34
PIK3R1 P27986 1/20 0.34
PIK3CA P42336 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5358762 0.82 CYP11B2 (0.40) CYP11B2ARLMNAMAPTKDM4E
SCHEMBL5354656 0.80 AR (0.40) CYP11B2ARLMNAMAPTKDM4E
SCHEMBL5365214 0.80 CYP11B2 (0.43) CYP11B2ARLMNAMAPTKDM4E
SCHEMBL6889076 0.79 AR (0.51) CYP11B2ARLMNAMAPTKDM4E
SCHEMBL5357164 0.78 CYP11B2 (0.39) CYP11B2ARLMNAMAPTKDM4E
SCHEMBL5368138 0.78 CYP11B2 (0.38) CYP11B2ARLMNAMAPTKDM4E
SCHEMBL5364131 0.75 CYP11B2 (0.40) CYP11B2ARLMNAMAPTKDM4E
SCHEMBL5362436 0.75 CYP11B2 (0.40) CYP11B2ARLMNAMAPTKDM4E
SCHEMBL14348315 0.75 CYP11B2 (0.40) CYP11B2ARLMNAMAPTKDM4E
SCHEMBL13362172 0.74 CYP11B2 (0.39) CYP11B2ARLMNAMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007145349-A2 SUBSTITUTED PYRROLE DERIVATIVES TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-12-21 WO disclosed